You’re right .
And I didn’t express well & asked for post to also be removed as it’s not clear or coherent or useful.
It’s not my field.
A friends wife died of bladder cancer. The oncologist was saying that they had to be careful in their last heroic treatment attempts - she ‘could only have a little bit more “ (Doxorubicin)
Cancer treatment has been horrendous .
Second surgeries are contraindicated in ovarian and really many cancers , bladder probably also notably .
Breast cancer treatment is moving to less surgical and non- radical surgical approaches .
I’m not clear , but there needs to be better chemo and effective but minimising extraneous harm , adjunctive targeted treatment. I’m sure bisantrene is a very useful oncology agent and a real alternative to existing drugs which can harm the heart . We all know this .
In combination tx though, and especially refractory and relapsed patients where resistance and ineffectiveness of existing SoC —it’s a no- brainer to get bisantrene into the clinic and helping to save patients , without the cardiac toxicity .
And if bisantrene can inhibit FTO in suitable patients where can be a diagnosed factor for cancer presence and growth and these patients will have very high mortality risks - wow.
If FTO inhibition link is strongly suggested through independent research ( as COH work has shown ) , + historical data & now current studies - this becomes overall most compelling in any cancer case, including specific breast cancer patients.
( In a paddock or your yard if there are weeds you spot treat them, with low- toxic agents , limit spray drift with highly targeted tiny spray nozzles only to the weed , or repeatedly if required apply the herbicide only right on the weed —-specific agents for the weed trying not to harm surrounding native or cultivated plants or the beneficial insects & tiny micro- fauna or have chemicals linger in the soil and environment , or hurt bees, native birds, animals or people etc )
Cancer is a similar analogy. Want to kill the cancer and not the person .
Heart damage is a terrible secondary outcome still especially for breast cancer survivors . SoC in breast cancer and other cancers as well is well- known for cardiac toxicity .
Grateful to many learned posters here in RAC forum , especially @Mason14 .
- Forums
- General
- General Comments / Chat
You’re right . And I didn’t express well & asked for post to...
-
- There are more pages in this discussion • 9,650 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.53 |
Change
-0.050(3.17%) |
Mkt cap ! $259.9M |
Open | High | Low | Value | Volume |
$1.58 | $1.59 | $1.51 | $174.6K | 113.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2372 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.59 | 141 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2372 | 1.525 |
2 | 14459 | 1.520 |
1 | 660 | 1.515 |
1 | 11000 | 1.505 |
2 | 10030 | 1.500 |
Price($) | Vol. | No. |
---|---|---|
1.585 | 141 | 1 |
1.620 | 2192 | 2 |
1.630 | 6499 | 2 |
1.640 | 4440 | 2 |
1.660 | 20000 | 1 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online